Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of LGALS2 mRNA | increases expression | 20713471
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of LGALS2 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of LGALS2 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of LGALS2 mRNA | decreases expression | 19128835
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LGALS2 mRNA | affects cotreatment|increases expression | 18164116
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene affects the expression of LGALS2 mRNA | affects expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of LGALS2 mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LGALS2 mRNA | affects cotreatment|increases expression | 18164116
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of LGALS2 mRNA | increases expression | 19638242
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of LGALS2 mRNA | affects cotreatment|increases expression | 17183730
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of LGALS2 mRNA | increases expression | 20713471
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of LGALS2 mRNA | decreases expression | 17426115
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of LGALS2 mRNA | decreases expression | 20106945
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of LGALS2 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.70 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.70 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.01 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.68 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.20 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.41 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.41 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
16.40 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
16.40 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
16.40 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
16.40 | 6695378 10545420 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
17.99 | 18056438 19052882 17162532 17620307 16434500 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
17.99 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
17.99 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.37 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.64 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.18 | 19183758 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.50 | 11922910 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 15238991 18940202 20603192 16609825 18985861 18775368 18558336 18177632 17507914 19460635 18316065 17688650 18396377 17157402 19232924 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.11 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
15.77 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.77 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.77 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.19 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.19 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
2.37 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.37 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.37 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.37 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.37 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.42 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
8.55 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.55 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.66 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.66 | 15073043 16217749 15553829 14691202 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.66 | 16878318 18785209 16502159 19394651 20514400 17428255 18393292 19335982 17761372 10737359 18788625 17978847 16328049 19383236 16681979 20935162 10672840 16540662 20432363 21159647 18056438 16698587 17055752 16288022 3084413 17162532 19052882 19171122 19919837 19107877 20214788 16807293 19539802 11831363 16935385 20007298 18494052 3581430 19208518 19519916 18210153 17173139 19701751 18971187 20727157 16779866 18691550 19418558 16569478 18665156 18506893 20101231 20512989 20524982 17138121 19822196 16830150 18978308 20084675 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.01 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.19 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.07 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
16.51 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
16.51 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
16.51 | 17174075 7505956 2727394 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
16.51 | 16192471 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.73 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.57 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.57 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.96 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.96 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 16354765 8697196 12621046 15668235 15340226 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.28 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.81 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.81 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.81 | 8888407 16575769 17688650 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.12 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.18 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.46 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.28 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.28 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.16 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
9.16 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.16 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
9.16 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.14 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.81 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.81 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 15322242 16714409 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.26 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.05 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.97 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.66 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.40 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.18 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.25 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.50 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.50 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
25.58 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
25.58 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
25.58 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
25.58 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
25.58 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.02 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.23 | 8888407 18558336 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
5.06 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.83 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.83 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.36 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.58 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.58 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.58 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.61 | 19772884 18467677 19176532 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.61 | 12621046 15340226 16120746 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.98 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 16354765 8697196 18606429 15340226 16959395 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.26 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.04 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.04 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.73 | 16612254 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.03 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.03 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.68 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.38 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.50 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.50 | 12371664 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.87 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.88 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.42 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.49 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.84 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.95 | 16968895 20471514 16467208 17050201 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.95 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.26 | 16112521 17217047 12712474 17869043 11468182 11161223 19642359 15336539 17712046 16330433 19075265 15748426 15213294 12679006 16891316 16331271 9834237 19225113 17649720 15622746 17107899 12018890 16823087 16966277 19035177 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.45 | 16882451 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.87 | 19638242 20032147 18407596 18522880 18665156 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.16 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.16 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.12 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
22.38 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
22.38 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
22.38 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
22.38 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
22.38 | 18977376 20137499 20101389 21167192 18648771 2862719 20452335 20492335 15175105 19833225 19812893 20405173 19254457 9163691 18754104 12771043 19294768 19996281 15885732 21071580 19426721 19255062 19690152 20434301 18644402 20501860 19499222 19551842 21278145 2422723 19850985 19090486 12112319 20118626 19642983 19256749 18978307 21047994 16942905 19073162 19638242 19427195 10737359 20583210 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
22.38 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
22.38 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
24.06 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
24.06 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
24.06 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
24.06 | 17854601 18079962 9362446 19539802 18164116 16267830 17942915 19004024 18093689 18544905 18253720 19009564 3124819 18775883 2563599 21159647 17174075 16842330 18308698 19519916 19126423 18282651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
24.06 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
24.06 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.41 | 15213294 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.40 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
6.69 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.69 | 20135361 18816296 6695378 20464547 17053015 18569708 20869020 20064080 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.69 | 20970405 6695378 20512841 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
6.69 | 1399818 21163286 9230183 20512841 16337739 10545420 7750092 6695378 16271038 11893704 15390079 17909032 20970405 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.69 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
3.63 | 11921183 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.25 | 18765137 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.25 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.16 | 15949261 19549372 14977855 11468182 19417148 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.61 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.11 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.81 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.56 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.56 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
marker/mechanism |
|
| |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.17 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.01 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.98 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.05 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.59 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.95 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.95 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.36 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.31 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.50 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.50 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.41 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.25 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.83 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.51 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.43 | 19769630 12452020 16624393 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.36 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.36 | 16540662 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.25 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.19 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.19 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.86 | 11896295 11118676 11222880 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.86 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.16 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.16 | 17292933 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.67 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.42 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.26 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.05 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.12 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.12 | 3137016 16876388 11044598 15475178 14763951 11738929 1511512 17978042 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.59 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.59 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.84 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.67 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.37 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.37 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.37 | 18456281 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.40 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.40 | 7505956 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.08 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.37 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.64 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.46 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
8.46 | 12845720 20435036 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.46 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.75 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.43 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |